首页 正文

Unlocking the therapeutic potential of HDAC8-degrading PROTACs: progress, challenges, and future directions

{{output}}
Histone deacetylase 8 (HDAC8) is a class I enzyme associated with various diseases, including cancer and neurological disorders. Although small-molecule HDAC inhibitors have been developed, their lack of selectivity often leads to off-target effects and toxici... ...